(0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Millennium Chelsea Harbour Hotel

2017年5月10日 (水) 午前 9:00 - 2017年5月11日 (木) 午後 5:30

Chelsea Harbour, London, SW10 0XG, United Kingdom

Pharmacovigilance Conference

Pharmacovigilance Update: Practical Approaches to Current Challenges - Interactive Session and Workshop Series

戻る Agenda

Session 7: Workshop on Risk Minimisation Measures and Effectiveness Evaluation

Session Chair(s)

Maarten Lagendijk, MSC

Maarten Lagendijk, MSC

Deputy EU QPPV

MSD, Netherlands

Inge Zomerdijk, MSC

Inge Zomerdijk, MSC

Pharmacovigilance Assessor

Medicines Evaluation Board (MEB), Netherlands

This 2- part intensive workshop will look into detailed practices in risk minimisation and give insights to effectiveness evaluation from both regulator and industry perspective. Attendees will get an overview of the regulatory framework and learn about the tools that can be used in different situations. Practical considerations related to standardisation, patient and healthcare professional materials will be addressed and the difference between aRMM at authorisation and aRMM post-marketing will be discussed. Furthermore, the implementation in different countries, local requirements, harmonisation and convergence between authorities will be explored, effectiveness measurement discussed, and participants will debate at what degree and when implementation is completed.

Speaker(s)

Maarten Lagendijk, MSC

Session 7 - Quiz

Maarten Lagendijk, MSC

MSD, Netherlands

Deputy EU QPPV

Inge Zomerdijk, MSC

Implementation of risk minimisation measures

Inge Zomerdijk, MSC

Medicines Evaluation Board (MEB), Netherlands

Pharmacovigilance Assessor

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。